In humans, aberrant expression of CDKN1A and/or CDKN1B in various carcinomas of lung, colorectum, cervix, head and neck leads to carcinogenesis by blocking DNA synthesis and inhibiting cell growth [43], [44], [45], [46]. Here, CDKN1B is linked to carcinoma.